EPM (@epmip) header
EPM (@epmip) profile picture

Our mission is to bridge the cannabis & pharmaceutical industries by increasing the potential development in cannabinoid-based pharmaceutical therapeutics.

ISRAEL
Joined September 2019
Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)Photo by EPM (@epmip)
היי, אנחנו epm 👋 אל תסתפקו בכותרות באתרים! אנחנו כאן כדי לדבר איתכם ולספק את כל המידע על ההנפקה הנגישה של החברה שנמצאת בעיצומה בימים אלה. בואו להכיר אותנו מקרוב: לעמוד ההנפקה>>https://teapawt.net/t.co/jZIi66mtjH לקבלת כל המידע באופן אישי>>https://teapawt.net/t.co/HcRBGS0zWY עקבו אחרינו לעדכונים.
EPM retweeted
Welcome to our delegates as you start to arrive for #IPWSO2022 with @PWSAI! Many thanks to our sponsors for making this event possible. @novonordisk @Radius_Health @fpwr @PWSAUSA @friendsofipwso @Saniona_AB Soleno Therapeutics @OT4Bfrance @epmip Aardvark Therapeutics
1
6
14
קצת על המדע מאחורי החברה: המחקרים והפיתוח מתבצעים בשיתוף עם אוניברסיטאות וחוקרים בעלי שם עולמי כגון: פרופ' דן פאר (אוני׳ תל-אביב), פרופ' יוסף (יוסי) תם (האוני׳ העברית), פרופ' מרק בראון (מדפארם) ועוד... עוד על שיתופי הפעולה והמחקרים האקדמיים, פה>>https://teapawt.net/t.co/HFFFiAKIpp
1
הנהלת החברה מתכבדת להכריז כי ההנפקה של EPM נפתחה מחדש בהצעה אחידה להזמנות הציבור. החברה ביצעה התאמות תוכן באתר Fundit ופרסמה תיקון תשקיף. לתשקיף החברה>>maya.tase.co.il/reports/deta… לעמוד ההנפקה>>https://teapawt.net/t.co/jZIi66mtjH מוזמנים להכנס ולעקוב.
An inspiring interview with Prof. Mechoulam and EPM about a new compound, EPM301, representing the future of cannabinoid acids as new medicine and potential alternative to steroid treatments.
1
2
An extraordinary interviewers rock star fantasy. The Mick Jaggers of cannabis science and business two countries same week. #cannamed #canex #laweekly #benzinga
1
2
8
Dr. Raphael Mechoulam has discovered a way to create safe and stable synthetic acid forms of THC and CBD, opening the doors for a wide range of new medical treatments. 👨🏻‍⚕️🧬🔬🧪 https://teapawt.net/t.co/hM3ChmK32b
2
28
2
54
Cannabis research pioneer hopes latest discovery is not overlooked — again ift.tt/2lTlVOB
6
5
Great discussion and collaboration at #CannMed2019! Learn more about EPM’s research, how our scientific team was able to industrialize a formula to manufacture stable #cannabinoid acids commercially, and how we are sharing the use of our molecules: epmip.com/#about-us
1
4
Prof. Dan Peer explains preclinical data presented at #CannMed2019 that shows promise of #cannabinoid acids in treating #IBD in animal models at @CannMedEvents. #CannMed2019 | #CannMedinspires | #CannabisScience| #CannabisHealth | #CannabisConference
3
6
Prof. Joseph Tam presented data at @CannMedEvents on the potential therapeutic benefits of #cannabinoidacids shown in animal models on diabetes-induced metabolic abnormalities. #CannMed2019 | #CannMedinspires | #CannabisScience| #CannabisHealth | #CannabisConference
Check out EPM’s CEO Reshef Swisa, speaking to @CannaBusinessMM of @LAWeekly about our mission to bridge the #cannabis and pharmaceutical industries through the company’s new therapeutics development platform. @Benzinga @MediGenomics #CannMedInspires | #CannMed2019
2
7
For the first time ever, pharmaceutical companies will have access to a wide variety of patent protected, stable cannabinoid molecules synthesized to provide stability and consistency for use in developing new medicines.
2
3
“We have taken the unstable acid molecules of the cannabis plant and synthesized them to provide a stable, consistent basis for researching new therapies across a wide range of medical needs.” – Prof. Raphael Mechoulam, PhD, head of research, EPM #CannMedInspires #CannMed2019
3
4
23
#NEWS: Today marks the start of a new era in medical research as EPM introduces an innovative development platform for the use of our fully stable acid-based #cannabinoid molecules at #CannMed2019. Learn more: epmip.com/epm-introduces-gro… #CannMedInspires
4
BIG NEWS! Prof. Raphael Mechoulam's keynote at CannMed 2019 will discuss development of new family of stabilized cannabinoid acids. Industry changing. One of last trips to US - are YOU coming to CannMed? Buy NOW! youtu.be/VKU9Uy5Eafo @CannMedEvents @MediGenomics @ProjectCBD
9
1
25
Prof. Dan Peer discusses how the company is at the forefront of pioneering #cannabinoid acid research with the potential to impact human health. #CannMedInspires | #CannabisScience| #CannabisHealth | #CannabisConference | #CannMed2019
5
5
The father of #cannabis research and #CannMed2019 keynote speaker, Dr. Raphael Mechoulam, explains EPM’s unprecedented work in #cannabinoid acid molecules. #CannMedInspires | #CannabisScience| #CannabisHealth | #CannabisConference
4
2
10
EPM was founded to unlock the potential of #cannabinoid acids and bridge the gap between the pharmaceutical and #cannabis industries. Stay tuned for groundbreaking news during #CannMed2019.
3
7